, Tracking Stock Market Picks
Enter Symbol:
Autodesk, Inc. (ADSK) [hlAlert]

Neutral ADSK

Autodesk, Inc. (ADSK) downgraded to Neutral with price target $20 by Robert W. Baird

Posted on: Friday,  Nov 21, 2008  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Neutral Autodesk, Inc. (NASDAQ: ADSK) on 11/21/2008. Previously Robert W. Baird rated Buy
Autodesk, Inc. (NASDAQ: ADSK) on 10/10/2007., when the stock price was $50.79. Since then, Autodesk, Inc. has lost 74.72% of its value until Robert W. Baird rated ADSK Outperform on 11/21/2008, when the price was $12.84. .

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/21/2011 8:25 AM Buy
41.05 46.00
as of 12/24/2008
1 Week up  6.32 %
1 Month up  32.52 %
3 Months down  -20.88 %
1 YTD up  0.15 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/21/2008 8:25 AM Hold
12.84 20.00
10/10/2007 9:25 AM Buy
50.79 57.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy